Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review.
作者： D. C. B. Lye , A. Hughes , D. O'Brien , E. Athan
DOI: 10.1007/S10096-005-0038-2
关键词:
摘要: Reported here is the case of a 72-year-old man who was diagnosed with Candida glabrata prosthetic mitral valve endocarditis and treated successfully fluconazole plus caspofungin after he refused determined unfit for surgery. Initial treatment intravenous amphotericin B resulted in acute renal impairment. Despite 8 days therapy, remained fungemic. Caspofungin added to regimen subsequent sterilisation blood culture. The patient 34 41 fluconazole. He continued oral hospital discharge well at follow-up 11 months later. role discussed.
springer.com
core.ac.uk 
sci-hub.se 参考文章(19)
Lígia C. Pierrotti, Larry M. Baddour, Fungal Endocarditis, 1995–2000 Chest. ,vol. 122, pp. 302- 310 ,(2002) , 10.1378/CHEST.122.1.302
Ethan Rubinstein, Eduardo R. Noriega, Michael S. Simberkoff, James J. Rahal, Tissue Penetration of Amphotericin B in Candida Endocarditis Chest. ,vol. 66, pp. 376- 377 ,(1974) , 10.1378/CHEST.66.4.376
Derek D. Muehrcke, Bruce W. Lytle, Delos M. Cosgrove, Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis The Annals of Thoracic Surgery. ,vol. 60, pp. 538- 543 ,(1995) , 10.1016/0003-4975(95)00469-2
Jorge Mora-Duarte, Robert Betts, Coleman Rotstein, Arnaldo Lopes Colombo, Luis Thompson-Moya, Juanita Smietana, Robert Lupinacci, Carole Sable, Nicholas Kartsonis, John Perfect, Comparison of caspofungin and amphotericin B for invasive candidiasis. The New England Journal of Medicine. ,vol. 347, pp. 2020- 2029 ,(2002) , 10.1056/NEJMOA021585
M. H. Nguyen, M. L. Nguyen, V. L. Vu, D. McMahon, T. F. Keys, M. Amidi, Candida Prosthetic Valve Endocarditis: Prospective Study of Six Cases and Review of the Literature Clinical Infectious Diseases. ,vol. 22, pp. 262- 267 ,(1996) , 10.1093/CLINIDS/22.2.262
Anastasia Antoniadou, Dimitrios P Kontoyiannis, Status of combination therapy for refractory mycoses. Current Opinion in Infectious Diseases. ,vol. 16, pp. 539- 545 ,(2003) , 10.1097/00001432-200312000-00005
Wojciech Mrówczyński, Michal Wojtalik, Caspofungin for Candida endocarditis. Pediatric Infectious Disease Journal. ,vol. 23, pp. 376- 376 ,(2004) , 10.1097/00006454-200404000-00029
D. M. Kuhn, T. George, J. Chandra, P. K. Mukherjee, M. A. Ghannoum, Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins Antimicrobial Agents and Chemotherapy. ,vol. 46, pp. 1773- 1780 ,(2002) , 10.1128/AAC.46.6.1773-1780.2002
L. P. Longman, S. A. Hibbert, M. V. Martin, Efficacy of fluconazole in prophylaxis and treatment of experimental Candida endocarditis. Clinical Infectious Diseases. ,vol. 12, ,(1990) , 10.1093/CLINIDS/12.SUPPLEMENT_3.S294
R. M. Prabhu, R. Orenstein, Failure of Caspofungin to Treat Brain Abscesses Secondary to Candida albicans Prosthetic Valve Endocarditis Clinical Infectious Diseases. ,vol. 39, pp. 1253- 1254 ,(2004) , 10.1086/424449